Avance BullishAs a result to the Covid-19 the LPG market fell way below their "fair-value", which is strongly indicated in the Price/ Earnings-value around 3.1-5.1.
The stock repeatedly shows a bullish RSI in the field between 50-75.
Besides the MacD indicator showing a strong momentum to proceed the trend
I personnel believe that the stock will try entering the same pattern as it did in the strong up-trend before the Covid-19 pandemic.
This would indicate a fair-value (relative to the value before the pandemic) around 70 NOK
SHLF looking bullish, looking for entrySo very brief analysis of SHLF, as it is definitively giving signs of life.
We have just arrived at major resistance that previously acted as support for a long time. So expecting a retrace from here, before even looking for a buying opportunity.
Furthermore a gap was left behind at 2.48 yesterday that will likely get filled. And we are inside the daily cloud --> consolidation.
I see 3 possible scenarios:
GREEN, Very bullish:
We break resistance and out of the cloud, we retest and continue up. Buy on the retest.
ORANGE, "normal":
We fill the gap, retest the bottom of the D cloud and find support in the cloud and on the 0.5 or 0.618 fib.
RED, "bottom formation":
We go back down looking for a bottom, possibly forming a double bottom or another bottom formation.
In conclusion; wait to see where SHLF starts to find support, or if it breaks up, look for the retest and buy.
SoftOx Infection remover - US Department of Defense (DoD) grantSoftOx, today announced the US Department of Defense (DoD) awarded SoftOx $1.977 million (USD) for research and development of the SoftOx Infection remover (Biofilm Eradicator).
Oslo 03.11.2020
The project is a research and development collaboration between SoftOx Solutions AS and leading US and European wound care clinics, focusing on chronic wounds and biofilm infections. The project represents an innovative treatment principle in how to prevent and treat biofilm infections in wounds. The grant will contribute to perform clinical investigations to evaluate the SoftOx technology in humans with serious non-healing wounds.
The award was issued on behalf of the Naval Medical Research Center (NMRC) under Medical Technology Enterprise Consortium (MTEC) a biomedical technology consortium that collaborates under a transaction agreement (OTA) with the US Army Medical Research and Development Command (USAMRDC). The award issued is entitled “Clinical Development of a New Antimicrobial Agent to Treat and Prevent Biofilm Formation in Wounds”. SoftOx considers it a great honor that one of the world’s leading research organizations supports the development and the technology of SoftOx by issuing the award.
About SoftOx Solutions
SoftOx Solutions AS (SoftOx, listed at Oslo Stock Exchange Merkur Market) is a Norwegian MedTech company based in Oslo with the aim to contribute to fight major threats to human health, namely; the Emergence of Antimicrobial Resistance (AMR), Biofilm Infections in Chronic Wounds and Spread of viruses. For more information about SoftOx please visit www.soft-ox.com
About Medical Technology Enterprise Consortium
MTEC is a biomedical technology consortium collaborating with multiple government agencies under a 10-year renewable Other Transactional Agreement with the U.S. Army Medical Research and Development Command. To find out more about MTEC, visit www.mtec-sc.org.
Possible break of trend line15 day EMA, indicates a test of a new high. Potentiel breakout from trendline, could cause new all time high
CrayonTwin 0.382 retracement coinciding with a channel support line.
Crayon has a habit of extending 1.618 of previous run before a correction (wave 3 = x1.618 wave 1), ranging back to 2018. If these extensions were applied to Wave 3 and to Wave 1→ peak Wave 3 and with a target being the channel resistance it would lead to a target somewhere within the red bubble in early 2021.
Wave 1 and Wave 3 have an almost identical % rise (128.2% and 126.9% respectively). If these % gains were applied to wave 5 at a place where it would coincide with the resistance line of the channel it would also lead to that target being met somewhere in early 2021 within the red bubble. However there is no guarantee there will be a third identical % rise and the prioritized target is the channel resistance line.